LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 1 | M06 | 72 | hr | 868 | 3606 | 3429 | 1.0514 | 1.0512 |
MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 2 | M06 | 72 | hr | 868 | 3823 | 3652 | 1.0468 | 1.0446 |
MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 3 | M06 | 72 | hr | 868 | 3838 | 3587 | 1.0699 | 1.0671 |
MDA-MB-231 | HG-6-64-01 | 0.12 | uM | LJP6 | 1 | M05 | 72 | hr | 868 | 3669 | 3429 | 1.0697 | 1.0692 |
MDA-MB-231 | HG-6-64-01 | 0.12 | uM | LJP6 | 2 | M05 | 72 | hr | 868 | 3661 | 3652 | 1.0025 | 1.0024 |
MDA-MB-231 | HG-6-64-01 | 0.12 | uM | LJP6 | 3 | M05 | 72 | hr | 868 | 3579 | 3587 | 0.9977 | 0.9977 |
MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 1 | M04 | 72 | hr | 868 | 2737 | 3429 | 0.7980 | 0.7848 |
MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 2 | M04 | 72 | hr | 868 | 2736 | 3652 | 0.7492 | 0.7399 |
MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 3 | M04 | 72 | hr | 868 | 2792 | 3587 | 0.7783 | 0.7695 |
MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 868 | 1684 | 3429 | 0.4910 | 0.3969 |
MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 868 | 1720 | 3652 | 0.4710 | 0.3908 |
MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 868 | 1644 | 3587 | 0.4583 | 0.3661 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 1 | M02 | 72 | hr | 868 | 870 | 3429 | 0.2537 | 0.0011 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 2 | M02 | 72 | hr | 868 | 1037 | 3652 | 0.2840 | 0.0895 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 3 | M02 | 72 | hr | 868 | 1228 | 3587 | 0.3423 | 0.1846 |
MDA-MB-231 | HG-6-64-01 | 10 | uM | LJP6 | 1 | M01 | 72 | hr | 868 | 509 | 3429 | 0.1484 | -0.2361 |
MDA-MB-231 | HG-6-64-01 | 10 | uM | LJP6 | 2 | M01 | 72 | hr | 868 | 452 | 3652 | 0.1238 | -0.2701 |
MDA-MB-231 | HG-6-64-01 | 10 | uM | LJP6 | 3 | M01 | 72 | hr | 868 | 618 | 3587 | 0.1723 | -0.1530 |
MDA-MB-231 | Neratinib | 0.04 | uM | LJP5 | 1 | A18 | 72 | hr | 868 | 2675 | 3286 | 0.8140 | 0.7968 |
MDA-MB-231 | Neratinib | 0.04 | uM | LJP5 | 2 | A18 | 72 | hr | 868 | 2403 | 3505 | 0.6855 | 0.6580 |
MDA-MB-231 | Neratinib | 0.04 | uM | LJP5 | 3 | A18 | 72 | hr | 868 | 2886 | 3440 | 0.8389 | 0.8307 |
MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 1 | A17 | 72 | hr | 868 | 2358 | 3286 | 0.7175 | 0.6825 |
MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 2 | A17 | 72 | hr | 868 | 2438 | 3505 | 0.6955 | 0.6700 |
MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 3 | A17 | 72 | hr | 868 | 2568 | 3440 | 0.7465 | 0.7262 |
MDA-MB-231 | Neratinib | 0.37 | uM | LJP5 | 1 | A16 | 72 | hr | 868 | 2225 | 3286 | 0.6771 | 0.6324 |